Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 2
2020 1
2021 2
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.
Gafar F, Wasmann RE, McIlleron HM, Aarnoutse RE, Schaaf HS, Marais BJ, Agarwal D, Antwi S, Bang ND, Bekker A, Bell DJ, Chabala C, Choo L, Davies GR, Day JN, Dayal R, Denti P, Donald PR, Engidawork E, Garcia-Prats AJ, Gibb D, Graham SM, Hesseling AC, Heysell SK, Idris MI, Kabra SK, Kinikar A, Kumar AKH, Kwara A, Lodha R, Magis-Escurra C, Martinez N, Mathew BS, Mave V, Mduma E, Mlotha-Mitole R, Mpagama SG, Mukherjee A, Nataprawira HM, Peloquin CA, Pouplin T, Ramachandran G, Ranjalkar J, Roy V, Ruslami R, Shah I, Singh Y, Sturkenboom MGG, Svensson EM, Swaminathan S, Thatte U, Thee S, Thomas TA, Tikiso T, Touw DJ, Turkova A, Velpandian T, Verhagen LM, Winckler JL, Yang H, Yunivita V, Taxis K, Stevens J, Alffenaar JC; Global Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in Pharmacokinetics of Anti-TB Drugs. Gafar F, et al. Among authors: ranjalkar j. Eur Respir J. 2023 Mar 9;61(3):2201596. doi: 10.1183/13993003.01596-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36328357 Free PMC article. Review.
Usage Pattern of Fixed-dose Combinations at ICMR Network of Rational Use of Medicine Centres across India: Recommendations for Policymakers and Prescribers.
Ranjalkar J, Jhaj R, Chandy SJ, Ight HR, Chugh PK, Tripathi CD, Badyal DK, Balakrishnan S, Medhi B, Kamat SK, Tripathi R, Dikshit H, Roy SS, Chatterjee S, Bhattacharjee M, Trivedi N, Desai C, Gupta P, Roy A, Raveendran R, Mathaiyan J, Kaushal S, Jain S, Kaul R, Kshirsagar NA. Ranjalkar J, et al. J Assoc Physicians India. 2023 Feb;71(2):11-12. doi: 10.5005/japi-11001-0175. J Assoc Physicians India. 2023. PMID: 37354468
Community engagement to mitigate antimicrobial resistance in low-and middle-income countries - an essential strategy for implementation of national action plans on AMR.
Mathew P, Chandy SJ, Ranjalkar J. Mathew P, et al. Among authors: ranjalkar j. Lancet Reg Health Southeast Asia. 2024 Mar 14;24:100379. doi: 10.1016/j.lansea.2024.100379. eCollection 2024 May. Lancet Reg Health Southeast Asia. 2024. PMID: 38510334 Free PMC article. No abstract available.
Evaluation of prescriptions from tertiary care hospitals across India for deviations from treatment guidelines & their potential consequences.
Shetty Y, Kamat S, Tripathi R, Parmar U, Jhaj R, Banerjee A, Balakrishnan S, Trivedi N, Chauhan J, Chugh PK, Tripathi CD, Badyal DK, Solomon L, Kaushal S, Gupta K, Jayanthi M, Jeevitha G, Chatterjee S, Samanta K, Desai C, Shah S, Medhi B, Joshi R, Prakash A, Gupta P, Roy A, Chandy S, Ranjalkar J, Bright HR, Dikshit H, Mishra H, Roy SS, Kshirsagar N. Shetty Y, et al. Among authors: ranjalkar j. Indian J Med Res. 2024 Feb 1;159(2):130-141. doi: 10.4103/ijmr.ijmr_2309_22. Epub 2024 Apr 4. Indian J Med Res. 2024. PMID: 38528817 Free PMC article.
14 results